Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May 13;17(1):28.
doi: 10.1186/s12910-016-0111-7.

Patient and interest organizations' views on personalized medicine: a qualitative study

Isabelle Budin-Ljøsne  1   2 , Jennifer R Harris  3
Affiliations

Patient and interest organizations' views on personalized medicine: a qualitative study

Isabelle Budin-Ljøsne et al. BMC Med Ethics. .

Abstract

Background: Personalized medicine (PM) aims to tailor disease prevention, diagnosis, and treatment to individuals on the basis of their genes, lifestyle and environments. Patient and interest organizations (PIOs) may potentially play an important role in the realization of PM. This paper investigates the views and perspectives on PM of a variety of PIOs.

Methods: Semi-structured telephone interviews were conducted among leading representatives of 13 PIOs located in Europe and North-America. The data collected were analysed using a conventional content analysis approach.

Results: The PIO representatives supported the realization of PM but feared that many financial, structural and organizational challenges may delay its realization. They encouraged strategies to modernize drug licencing mechanisms, develop research and data sharing infrastructures, and educate patients and health care professionals in PM. Notably, they emphasized the importance of developing PM in an equitable way and taking into consideration the patients' needs, values and personal situation. Despite varying levels of awareness regarding PM, the PIO representatives expressed willingness to engage in the PM agenda and recommended that PIOs work closely with policy-makers to design PM in a way that truly addresses the needs and concerns of patients.

Conclusions: PIOs have the potential to become central drivers of the PM agenda. Collaborations should be further developed between PIOs, researchers, drug developers and health care authorities.

Keywords: Ethics; Genetics; Patient organizations; Personalized medicine; Precision medicine.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Godman B, Finlayson AE, Cheema PK, Zebedin-Brandl E, Gutierrez-Ibarluzea I, Jones J, et al. Personalizing health care: feasibility and future implications. BMC Med. 2013;11:179. doi: 10.1186/1741-7015-11-179. - DOI - PMC - PubMed
    1. Fact sheet: President Obama’s Precision Medicine Initiative. https://www.whitehouse.gov/the-press-office/2015/01/30/fact-sheet-presid.... Accessed 4 Dec 2015.
    1. European Commission. Personalised Medicine. http://ec.europa.eu/health/human-use/personalised-medicine/index_en.htm. Accessed 4 Dec 2015.
    1. Committee on a Framework for Development of a New Taxonomy of Disease. National Research Council of the National Academies. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease. The National Academies Press; 2011. http://www.ncbi.nlm.nih.gov/books/NBK91503/. Accessed 4 Dec 2015. - PubMed
    1. European Science Foundation. ESF Forward Look: Personalised Medicine for the European Citizen. Towards more precise medicine for the diagnosis, treatment and prevention of diseases. http://www.esf.org/coordinating-research/forward-looks/biomedical-scienc...http://www.esf.org/index.php?eID=tx_nawsecuredl&u=0&g=0&t=1449323277&has.... Accessed 4 Dec 2015.

Publication types